top of page

About

What is advanced diabetic infusion treatment (ADIT)?

Our innovative approach is where insulin is administered as a hormone rather than a drug. In so doing, the primary cause of diabetes, metabolic failure, is targeted. Traditional approaches like insulin drugs and shots aim for symptom suppression only.

 

How does it help?

By utilizing insulin in a way that mimics normal physiology, we are able to reduce insulin resistance, which helps blood sugar more easily enter each cell and be converted into energy. Increasing cellular energy allows damaged tissues and organs to grow, repair, and regenerate. ADIT not only stabilizes, but in many instances can reverse complications of diabetes along with other metabolic disorders.

Schull institute study - insulin therapy on diabetic complications (Oct 27, 2015) retrospective, observational study (n=60) reported

95% improvement or elimination in neuropathy

76% improvement in at least one diabetic condition

63% reported hba1c reduction.

41% reduced need for at least one medication

What can I expect when I schedule a diabetic infusion treatment?

First our commitment is to improve your symptoms while addressing root cause of your diabetes. 

 

OUR CARE PLAN

Every patient is unique so we must establish their degree of insulin resistance and the efficacy of their carbohydrate metabolism. This allows us to determine the medical necessity and establish a physician directed care plan.

Each patient’s care plan typically includes:

INDUCTION PHASE

We outline the number and frequency of infusions from induction through to maintenance. The typical induction phase is two infusions per week and reducing to one per week for about 12 sessions.

MAINTENANCE PHASE

Here we focus on finding the balance between an optimized metabolism and insulin sensitivity while extending as much time as possible between treatments.

Once the plan is in place, patients arrive at one of our centers dedicated to the needs of our infusion patients. One of our clinical specialists will guide each patient through the procedure. An infusion set connects the insulin pump delivery device to the body. It works the same way as an intravenous line does.

Frequently Asked Questions

 

Optional stu/ some research

In a new England journal of medicine study in the UK in 2018, bally, et. al. chose 136 adults with type 2 diabetes who required subcutaneous insulin therapy to receive either closed-loop insulin delivery (70 patients) or conventional subcutaneous insulin therapy, according to usual practice (66 patients). They concluded:

“Among inpatients with type 2 diabetes receiving noncritical care, the use of an automated, closed-loop insulin-delivery system resulted in significantly better glycemic control than conventional subcutaneous insulin therapy, without a higher risk of hypoglycemia.” (new England journal med 2018; 379:547-556
Doi: 10.1056/nejmoa1805233)

International journal of diabetes and metabolic disorders (July 2021) case series: reversal of diabetic neuropathy utilizing physiologic insulin resensitization. tucker et. al. found:  “In our case study, we present two patients who initially experienced a loss of sensation in their extremities and decreased wound healing. Using pir treatment, we demonstrate that both patients experienced neuropathy reversal and improved wound healing.”

International journal of molecular sciences (February 2022) greenway’s team showed: “there is consistent evidence that this treatment modality can reverse the diabetes-associated complications of neuropathy, diabetic ulcers, nephropathy, and retinopathy, and that it lowers hba1c. In conclusion, physiologic insulin resensitization has a persuasive scientific basis, significant treatment potential, and likely cost benefits.”

 

A1 C Infusion

What is it?

It is a groundbreaking multi-patented approach where insulin is administered as a hormone rather than a drug. In so doing, the primary cause of diabetes, metabolic failure, is targeted. Traditional approaches like insulin drugs and shots aim for symptom suppression only. 

How does it help?

By utilizing insulin in a way that mimics normal physiology, we are able to reduce insulin resistance, which helps blood sugar more easily enter each cell and be converted into energy. Increasing cellular energy allows damaged tissues and organs to grow, repair, and regenerate. A1C Infusion not only stabilizes, but in many instances can reverse complications of diabetes along with other metabolic disorders.

 

Optional stuff some research

In a New England Journal of Medicine study in the UK in 2018, Bally, et. al. chose 136 adults with type 2 diabetes who required subcutaneous insulin therapy to receive either closed-loop insulin delivery (70 patients) or conventional subcutaneous insulin therapy, according to usual practice (66 patients). They concluded:

“Among inpatients with type 2 diabetes receiving noncritical care, the use of an automated, closed-loop insulin-delivery system resulted in significantly better glycemic control than conventional subcutaneous insulin therapy, without a higher risk of hypoglycemia.” (New England Journal Med 2018; 379:547-556
DOI: 10.1056/NEJMoa1805233)

 

International Journal of Diabetes and Metabolic Disorders (July 2021) Case Series: Reversal of Diabetic Neuropathy Utilizing Physiologic Insulin Resensitization. Tucker et. al. found:  “ In our case study, we present two patients who initially experienced a loss of sensation in their extremities and decreased wound healing. Using PIR treatment, we demonstrate that both patients experienced neuropathy reversal and improved wound healing.”

International Journal of Molecular Sciences (February 2022) Greenway’s team showed: “There is consistent evidence that this treatment modality can reverse the diabetes-associated complications of neuropathy, diabetic ulcers, nephropathy, and retinopathy, and that it lowers HbA1c. In conclusion, physiologic insulin resensitization has a persuasive scientific basis, significant treatment potential, and likely cost benefits.”


ADIT focuses primarily on patients with metabolic disorders, such as type 1, type 2, prediabetes, and insulin resistance. Every patient’s degree of insulin resistance and efficiency of metabolism is unique. We begin with a consultation with a qualified physicians and or nurse practitioners to determine medical necessity.

Is this the treatment for me?

What is the process?

After evaluation, a physician-directed, individualized care plan is formulated. Each patient’s care plan includes a schedule outlining the number and frequency of infusions from introduction through to maintenance.

 

No. Clinics and health care facilities all over Europe have been certified in the last few years to provide this treatment. Research on these treatments have proven very positive.  It is now FDA approved in the us.

Is this a new treatment?

Will my insurance pay for this?

Most large insurance companies including Medicare and Medicaid will fully cover the cost. In some instances, there may be a nominal co-pay.

 

Fill out and submit the “information form” and one of our clinical specialists will be in contact as soon as possible.

How do I take the first step?

Is this the treatment for me?

 

A1C focuses primarily on patients with metabolic disorders, such as Type 1, Type 2, prediabetes, and insulin resistance. Every patient’s degree of insulin resistance and efficiency of metabolism is unique. We begin with a consultation with a qualified physician to determine medical necessity.

What is the process?

After evaluation, a physician-directed, individualized care plan is formulated. Each patient’s care plan includes a schedule outlining the number and frequency of infusions from introduction through to maintenance.

Once the plan is in place, patients arrive at one of our centers dedicated to the needs of our infusion patients. One of our clinical specialists will guide each patient through the procedure. An infusion set connects the insulin pump delivery device to the body. It works the same way as an intravenous line does.

Is this a new treatment?

No. Clinics and health care facilities all over Europe have been certified in the last few years to provide this treatment. Research on these treatments have proven very positive.  It is now FDA approved in the US.

Will my insurance pay for this?

Most large insurance companies including Medicare and Medicaid will fully cover the cost. In some instances, there may be a nominal co-pay.

Fill out and submit the “Information Form” and one of our clinical specialists will be in contact as soon as possible.

How do I take the first step?

© 2024  PINNACLE WELL HEALTH, LLC

bottom of page